Back9 Meters Biopharma Overview

9 Meters Biopharma Accounts Payable

Track 9 Meters Biopharma's accounts payable ($4.2M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$4.23M
↑ 121.31% YoYΔ $2.32M vs prior year quarter

Peer trimmed avg / median

Loading

9 Meters Biopharma Accounts Payable History

Loading

9 Meters Biopharma vs. peers: Accounts Payable Comparison

Loading

9 Meters Biopharma Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

9 Meters Biopharma (NMTR) FAQ

As of the most recent data (March 2023), NMTR shows a accounts payable of $4.2M. That compares with $1.9M in the prior-year period — up 121.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NMTR's accounts payable is now $4.2M (was $1.9M) — a 121.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether 9 Meters Biopharma is outperforming or lagging.

Tracking NMTR's accounts payable over time shows whether 9 Meters Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $4.2M That compares with $1.9M in the prior-year period — up 121.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has 9 Meters Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $4.2M) with ownership activity and broader fundamentals.

9 Meters Biopharma's accounts payable is $4.2M; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.